227 filings
Page 3 of 12
8-K
c6yanpj6o24
6 Aug 21
NeoGenomics Reports 40% Revenue Growth to $122 Million
7:10am
8-K/A
gcb f8e16
15 Jul 21
Departure of Directors or Certain Officers
4:39pm
8-K
v244rahuule
7 Jul 21
Departure of Directors or Certain Officers
5:21pm
8-K
oc6vj38
24 Jun 21
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
4:45pm
8-K
6uaode
8 Jun 21
Other Events
5:07pm
8-K
95n5ou
1 Jun 21
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
gxdccg5 h034s
6 May 21
Regulation FD Disclosure
5:07pm
8-K
ns5916s7xx
5 May 21
Departure of Directors or Certain Officers
7:36am
8-K
hfwrbv2z8
5 May 21
NeoGenomics Reports 9% Revenue Growth to $116 Million
7:32am
8-K
r5g jnj7qflof
5 May 21
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy
7:31am
8-K
oavui
5 May 21
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy
7:30am
8-K
dr7tih ho
15 Apr 21
Departure of Directors or Certain Officers
4:42pm
8-K
kqg6lzja
15 Apr 21
Other Events
4:40pm
8-K
x89zv1raueo
7 Apr 21
Other Events
5:23pm
8-K
thi67uzlpcke0tpq8
24 Mar 21
NeoGenomics Agrees to Acquire Trapelo Health
4:45pm
8-K
m5lz0
1 Mar 21
Departure of Directors or Certain Officers
4:45pm
8-K
9pg jd0r71v
25 Feb 21
Regulation FD Disclosure
5:08pm
8-K
kuauzd5mbdmiry8pg
24 Feb 21
NeoGenomics Reports 18% Revenue Growth to $126 Million
7:51am
8-K
xmpe4f329kwb3 ru7
11 Jan 21
Regulation FD Disclosure
5:16pm
8-K
8ev7935xp6
11 Jan 21
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:13pm